Literature DB >> 30496103

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017.

.   

Abstract

BACKGROUND: Global development goals increasingly rely on country-specific estimates for benchmarking a nation's progress. To meet this need, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 estimated global, regional, national, and, for selected locations, subnational cause-specific mortality beginning in the year 1980. Here we report an update to that study, making use of newly available data and improved methods. GBD 2017 provides a comprehensive assessment of cause-specific mortality for 282 causes in 195 countries and territories from 1980 to 2017.
METHODS: The causes of death database is composed of vital registration (VR), verbal autopsy (VA), registry, survey, police, and surveillance data. GBD 2017 added ten VA studies, 127 country-years of VR data, 502 cancer-registry country-years, and an additional surveillance country-year. Expansions of the GBD cause of death hierarchy resulted in 18 additional causes estimated for GBD 2017. Newly available data led to subnational estimates for five additional countries-Ethiopia, Iran, New Zealand, Norway, and Russia. Deaths assigned International Classification of Diseases (ICD) codes for non-specific, implausible, or intermediate causes of death were reassigned to underlying causes by redistribution algorithms that were incorporated into uncertainty estimation. We used statistical modelling tools developed for GBD, including the Cause of Death Ensemble model (CODEm), to generate cause fractions and cause-specific death rates for each location, year, age, and sex. Instead of using UN estimates as in previous versions, GBD 2017 independently estimated population size and fertility rate for all locations. Years of life lost (YLLs) were then calculated as the sum of each death multiplied by the standard life expectancy at each age. All rates reported here are age-standardised.
FINDINGS: At the broadest grouping of causes of death (Level 1), non-communicable diseases (NCDs) comprised the greatest fraction of deaths, contributing to 73·4% (95% uncertainty interval [UI] 72·5-74·1) of total deaths in 2017, while communicable, maternal, neonatal, and nutritional (CMNN) causes accounted for 18·6% (17·9-19·6), and injuries 8·0% (7·7-8·2). Total numbers of deaths from NCD causes increased from 2007 to 2017 by 22·7% (21·5-23·9), representing an additional 7·61 million (7·20-8·01) deaths estimated in 2017 versus 2007. The death rate from NCDs decreased globally by 7·9% (7·0-8·8). The number of deaths for CMNN causes decreased by 22·2% (20·0-24·0) and the death rate by 31·8% (30·1-33·3). Total deaths from injuries increased by 2·3% (0·5-4·0) between 2007 and 2017, and the death rate from injuries decreased by 13·7% (12·2-15·1) to 57·9 deaths (55·9-59·2) per 100 000 in 2017. Deaths from substance use disorders also increased, rising from 284 000 deaths (268 000-289 000) globally in 2007 to 352 000 (334 000-363 000) in 2017. Between 2007 and 2017, total deaths from conflict and terrorism increased by 118·0% (88·8-148·6). A greater reduction in total deaths and death rates was observed for some CMNN causes among children younger than 5 years than for older adults, such as a 36·4% (32·2-40·6) reduction in deaths from lower respiratory infections for children younger than 5 years compared with a 33·6% (31·2-36·1) increase in adults older than 70 years. Globally, the number of deaths was greater for men than for women at most ages in 2017, except at ages older than 85 years. Trends in global YLLs reflect an epidemiological transition, with decreases in total YLLs from enteric infections, respiratory infections and tuberculosis, and maternal and neonatal disorders between 1990 and 2017; these were generally greater in magnitude at the lowest levels of the Socio-demographic Index (SDI). At the same time, there were large increases in YLLs from neoplasms and cardiovascular diseases. YLL rates decreased across the five leading Level 2 causes in all SDI quintiles. The leading causes of YLLs in 1990-neonatal disorders, lower respiratory infections, and diarrhoeal diseases-were ranked second, fourth, and fifth, in 2017. Meanwhile, estimated YLLs increased for ischaemic heart disease (ranked first in 2017) and stroke (ranked third), even though YLL rates decreased. Population growth contributed to increased total deaths across the 20 leading Level 2 causes of mortality between 2007 and 2017. Decreases in the cause-specific mortality rate reduced the effect of population growth for all but three causes: substance use disorders, neurological disorders, and skin and subcutaneous diseases.
INTERPRETATION: Improvements in global health have been unevenly distributed among populations. Deaths due to injuries, substance use disorders, armed conflict and terrorism, neoplasms, and cardiovascular disease are expanding threats to global health. For causes of death such as lower respiratory and enteric infections, more rapid progress occurred for children than for the oldest adults, and there is continuing disparity in mortality rates by sex across age groups. Reductions in the death rate of some common diseases are themselves slowing or have ceased, primarily for NCDs, and the death rate for selected causes has increased in the past decade. FUNDING: Bill & Melinda Gates Foundation.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2018        PMID: 30496103      PMCID: PMC6227606          DOI: 10.1016/S0140-6736(18)32203-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  51 in total

Review 1.  A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Authors:  Debra A Goff; Ravina Kullar; Ellie J C Goldstein; Mark Gilchrist; Dilip Nathwani; Allen C Cheng; Kelly A Cairns; Kevin Escandón-Vargas; Maria Virginia Villegas; Adrian Brink; Dena van den Bergh; Marc Mendelson
Journal:  Lancet Infect Dis       Date:  2016-11-18       Impact factor: 25.071

2.  Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis.

Authors:  Hannah Blencowe; Vijaya Kancherla; Sowmiya Moorthie; Matthew W Darlison; Bernadette Modell
Journal:  Ann N Y Acad Sci       Date:  2018-01-24       Impact factor: 5.691

3.  Pain as a global public health priority.

Authors:  Daniel S Goldberg; Summer J McGee
Journal:  BMC Public Health       Date:  2011-10-06       Impact factor: 3.295

4.  Algorithms for enhancing public health utility of national causes-of-death data.

Authors:  Mohsen Naghavi; Susanna Makela; Kyle Foreman; Janaki O'Brien; Farshad Pourmalek; Rafael Lozano
Journal:  Popul Health Metr       Date:  2010-05-10

Review 5.  Addressing the global tragedy of needless pain: rethinking the United Nations single convention on narcotic drugs.

Authors:  Allyn L Taylor
Journal:  J Law Med Ethics       Date:  2007       Impact factor: 1.718

6.  Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.

Authors:  Kyle J Foreman; Neal Marquez; Andrew Dolgert; Kai Fukutaki; Nancy Fullman; Madeline McGaughey; Martin A Pletcher; Amanda E Smith; Kendrick Tang; Chun-Wei Yuan; Jonathan C Brown; Joseph Friedman; Jiawei He; Kyle R Heuton; Mollie Holmberg; Disha J Patel; Patrick Reidy; Austin Carter; Kelly Cercy; Abigail Chapin; Dirk Douwes-Schultz; Tahvi Frank; Falko Goettsch; Patrick Y Liu; Vishnu Nandakumar; Marissa B Reitsma; Vince Reuter; Nafis Sadat; Reed J D Sorensen; Vinay Srinivasan; Rachel L Updike; Hunter York; Alan D Lopez; Rafael Lozano; Stephen S Lim; Ali H Mokdad; Stein Emil Vollset; Christopher J L Murray
Journal:  Lancet       Date:  2018-10-16       Impact factor: 79.321

Review 7.  Essential medicines for universal health coverage.

Authors:  Veronika J Wirtz; Hans V Hogerzeil; Andrew L Gray; Maryam Bigdeli; Cornelis P de Joncheere; Margaret A Ewen; Martha Gyansa-Lutterodt; Sun Jing; Vera L Luiza; Regina M Mbindyo; Helene Möller; Corrina Moucheraud; Bernard Pécoul; Lembit Rägo; Arash Rashidian; Dennis Ross-Degnan; Peter N Stephens; Yot Teerawattananon; Ellen F M 't Hoen; Anita K Wagner; Prashant Yadav; Michael R Reich
Journal:  Lancet       Date:  2016-11-08       Impact factor: 79.321

8.  Establishing the Africa Centres for Disease Control and Prevention: responding to Africa's health threats.

Authors:  John N Nkengasong; Olawale Maiyegun; Matshidiso Moeti
Journal:  Lancet Glob Health       Date:  2017-01-18       Impact factor: 26.763

9.  Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

Authors: 
Journal:  Lancet       Date:  2016-10-08       Impact factor: 79.321

10.  The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study.

Authors:  Karen L Kotloff; William C Blackwelder; Dilruba Nasrin; James P Nataro; Tamer H Farag; Annemieke van Eijk; Richard A Adegbola; Pedro L Alonso; Robert F Breiman; Abu Syed Golam Faruque; Debasish Saha; Samba O Sow; Dipika Sur; Anita K M Zaidi; Kousick Biswas; Sandra Panchalingam; John D Clemens; Dani Cohen; Roger I Glass; Eric D Mintz; Halvor Sommerfelt; Myron M Levine
Journal:  Clin Infect Dis       Date:  2012-12       Impact factor: 9.079

View more
  1563 in total

1.  The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017.

Authors:  Melissa R Laughter; Mayra B C Maymone; Chante Karimkhani; Chandler Rundle; Sophia Hu; Sophia Wolfe; Katrina Abuabara; Parker Hollingsworth; Gil S Weintraub; Cory A Dunnick; Adnan Kisa; Giovanni Damiani; Aziz Sheikh; Jasvinder A Singh; Takeshi Fukumoto; Rupak Desai; Ayman Grada; Irina Filip; Amir Radfar; Mohsen Naghavi; Robert P Dellavalle
Journal:  JAMA Dermatol       Date:  2020-08-01       Impact factor: 10.282

2.  Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial.

Authors:  Peter J McCartney; Hany Eteiba; Annette M Maznyczka; Margaret McEntegart; John P Greenwood; Douglas F Muir; Saqib Chowdhary; Anthony H Gershlick; Clare Appleby; James M Cotton; Andrew Wragg; Nick Curzen; Keith G Oldroyd; Mitchell Lindsay; J Paul Rocchiccioli; Aadil Shaukat; Richard Good; Stuart Watkins; Keith Robertson; Christopher Malkin; Lynn Martin; Lynsey Gillespie; Thomas J Ford; Mark C Petrie; Peter W Macfarlane; R Campbell Tait; Paul Welsh; Naveed Sattar; Robin A Weir; Keith A Fox; Ian Ford; Alex McConnachie; Colin Berry
Journal:  JAMA       Date:  2019-01-01       Impact factor: 56.272

Review 3.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

Review 4.  Urokinase Plasminogen Activator: A Potential Thrombolytic Agent for Ischaemic Stroke.

Authors:  Rais Reskiawan A Kadir; Ulvi Bayraktutan
Journal:  Cell Mol Neurobiol       Date:  2019-09-24       Impact factor: 5.046

5.  Healthcare disparities for women hospitalized with myocardial infarction and angina.

Authors:  Alice M Jackson; Ruiqi Zhang; Iain Findlay; Keith Robertson; Mitchell Lindsay; Tamsin Morris; Brian Forbes; Richard Papworth; Alex McConnachie; Kenneth Mangion; Pardeep S Jhund; Colin McCowan; Colin Berry
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2020-04-01

6.  Global, Regional, National, and Subnational Big Data to Inform Health Equity Research: Perspectives from the Global Burden of Disease Study 2017.

Authors:  Ali H Mokdad; George A Mensah; Varsha Krish; Scott D Glenn; Molly K Miller-Petrie; Alan D Lopez; Christopher J L Murray
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

7.  Index of microvascular resistance and outcomes following intra-coronary thrombolysis with percutaneous intervention in STEMI: a meta-analysis of randomized control trials.

Authors:  Ashish Kumar; Mariam Shariff; Rajkumar Doshi
Journal:  J Thromb Thrombolysis       Date:  2020-04       Impact factor: 2.300

Review 8.  Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.

Authors:  Adam N Berman; Ron Blankstein
Journal:  Curr Cardiol Rep       Date:  2019-08-05       Impact factor: 2.931

9.  Association of predicted lean body mass and fat mass with cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Zhenhua Xing; Liang Tang; Jian Chen; Junyu Pei; Pengfei Chen; Zhenfei Fang; Shenghua Zhou; Xinqun Hu
Journal:  CMAJ       Date:  2019-09-23       Impact factor: 8.262

10.  Machine-learning model to predict the cause of death using a stacking ensemble method for observational data.

Authors:  Chungsoo Kim; Seng Chan You; Jenna M Reps; Jae Youn Cheong; Rae Woong Park
Journal:  J Am Med Inform Assoc       Date:  2021-06-12       Impact factor: 4.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.